BMS-509744
|
B608130-10mg
|
Moligand™, ≥98% |
439575-02-7 |
10mg
|
¥ 1899.9
|
期货,请咨询 |
阿拉丁 |
binodenoson
|
B608093-1mg
|
Moligand™, ≥95% |
144348-08-3 |
1mg
|
¥ 1099.9
|
现货 |
阿拉丁 |
binodenoson
|
B608093-10mg
|
Moligand™, ≥95% |
144348-08-3 |
10mg
|
¥ 4299.9
|
现货 |
阿拉丁 |
BAY-73-1449
|
B607951-50mg
|
Moligand™, ≥97% |
693790-96-4 |
50mg
|
¥ 7999.9
|
现货 |
阿拉丁 |
BAY-73-1449
|
B607951-1mg
|
Moligand™, ≥97% |
693790-96-4 |
1mg
|
¥ 899.9
|
现货 |
阿拉丁 |
BAY-73-1449
|
B607951-10mg
|
Moligand™, ≥97% |
693790-96-4 |
10mg
|
¥ 3699.9
|
现货 |
阿拉丁 |
BAY-73-1449
|
B607951-100mg
|
Moligand™, ≥97% |
693790-96-4 |
100mg
|
¥ 10999.9
|
现货 |
阿拉丁 |
BAY-545
|
B607946-1mg
|
Moligand™, ≥98% |
1699717-32-2 |
1mg
|
¥ 899.9
|
现货 |
阿拉丁 |
BAY-545
|
B607946-10mg
|
Moligand™, ≥98% |
1699717-32-2 |
10mg
|
¥ 4199.9
|
现货 |
阿拉丁 |
Boc-Val-Cit-PAB
|
B597026-100mg
|
≥97% |
870487-09-5 |
100mg
|
¥ 629.9
|
现货 |
阿拉丁 |
Boc-Val-Cit-OH
|
B597025-5g
|
≥95% |
870487-08-4 |
5g
|
¥ 399.9
|
现货 |
阿拉丁 |
Boc-Val-Cit-OH
|
B597025-25g
|
≥95% |
870487-08-4 |
25g
|
¥ 1899.9
|
现货 |
阿拉丁 |
双-PEG10-琥珀酰亚胺酯
|
B596578-25mg
|
≥98% |
2221949-02-4 |
25mg
|
¥ 699.9
|
现货 |
阿拉丁 |
Vonlerolizumab (anti-OX40)
|
Ab175702-10mg
|
Moligand™, RUO, ≥95%(SDS-PAGE&SEC), Lot by Lot |
1638935-72-4 |
10mg
|
¥ 9399.9
|
期货,请咨询 |
阿拉丁 |
Trastuzumab emtansine (anti-ERBB2)
|
Ab175686-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1018448-65-1 |
10mg
|
¥ 22229.9
|
期货,请咨询 |
阿拉丁 |
Tisotumab vedotin (anti-Tissue Factor)
|
Ab175681-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1418731-10-8 |
10mg
|
¥ 30299.9
|
期货,请咨询 |
阿拉丁 |
Rovelizumab (anti-CD11a&CD18)
|
Ab175649-10mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
339086-79-2 |
10mg
|
¥ 13839.9
|
期货,请咨询 |
阿拉丁 |
Ozoralizumab (anti-TNF-alpha&HSA)
|
Ab175623-10mg
|
Carrier Free, 重组, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1167985-17-2 |
10mg
|
¥ 15199.9
|
期货,请咨询 |
阿拉丁 |
Lifastuzumab vedotin (anti-SLC34A2)
|
Ab175578-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1401812-88-1 |
10mg
|
¥ 30299.9
|
期货,请咨询 |
阿拉丁 |
Indusatumab vedotin (anti-GUCY2C)
|
Ab175563-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1514889-12-3 |
10mg
|
¥ 30299.9
|
期货,请咨询 |
阿拉丁 |
Glembatumumab vedotin (anti-GPNMB)
|
Ab175551-10mg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1182215-65-1 |
10mg
|
¥ 25499.9
|
期货,请咨询 |
阿拉丁 |
Iscalimab (anti-CD40)
|
Ab175491-10mg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC) |
2031153-61-2 |
10mg
|
¥ 15999.9
|
期货,请咨询 |
阿拉丁 |
Albuvirtide(TFA salt)
|
A671341-1mg
|
≥95% |
1417179-66-8 |
1mg
|
¥ 2999.9
|
现货 |
阿拉丁 |
Atilmotin
|
A671286-1mg
|
|
533927-56-9 |
1mg
|
¥ 2999.9
|
期货,请咨询 |
阿拉丁 |